- Investing Ideas
- South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
South Korean Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
25
Mid-Large Cap Stocks
25 companies
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩336,500.00
7D
5.3%
1Y
-40.7%
Yuhan
Market Cap: ₩5.3t
Operates as a pharmaceutical company in South Korea and internationally.
A000100
₩70,800.00
7D
3.4%
1Y
-46.4%
Samsung BiologicsLtd
Market Cap: ₩64.6t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,396,000.00
7D
0.07%
1Y
-13.6%
SK bioscienceLtd
Market Cap: ₩2.8t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩35,450.00
7D
-3.3%
1Y
-25.7%
Hanall Biopharma
Market Cap: ₩2.7t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩52,800.00
7D
-8.0%
1Y
80.2%
L&C BIOLTD
Market Cap: ₩1.9t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩71,000.00
7D
-2.3%
1Y
137.9%
Samsung Epis Holdings
Market Cap: ₩9.9t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩396,000.00
7D
3.0%
1Y
n/a
D&D Pharmatech
Market Cap: ₩3.1t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩68,700.00
7D
-18.5%
1Y
78.3%
Hanmi Pharm
Market Cap: ₩4.9t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩386,000.00
7D
-0.8%
1Y
32.0%
Peptron
Market Cap: ₩2.8t
Engages in the development of peptide-based medicines.
A087010
₩119,200.00
7D
6.8%
1Y
-59.5%
NatureCellLtd
Market Cap: ₩1.6t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩25,000.00
7D
-0.8%
1Y
-9.4%
ABL Bio
Market Cap: ₩4.2t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩75,600.00
7D
-7.6%
1Y
1.7%
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,400.00
7D
-3.6%
1Y
-22.9%
ALTEOGEN
Market Cap: ₩14.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩276,500.00
7D
-14.7%
1Y
-43.6%
Hugel
Market Cap: ₩2.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩239,500.00
7D
-0.4%
1Y
-33.4%
Celltrion Pharm
Market Cap: ₩1.8t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩39,800.00
7D
-2.9%
1Y
-26.1%
Mezzion PharmaLtd
Market Cap: ₩1.6t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩52,900.00
7D
-6.5%
1Y
33.9%
Caregen
Market Cap: ₩3.0t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩61,700.00
7D
1.0%
1Y
22.9%
Kolon TissueGene
Market Cap: ₩5.3t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩62,100.00
7D
-31.0%
1Y
41.5%
Celltrion
Market Cap: ₩40.3t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩175,800.00
7D
0.3%
1Y
2.4%
ST PharmLtd
Market Cap: ₩2.6t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩124,300.00
7D
0.6%
1Y
32.4%
Sam Chun Dang Pharm
Market Cap: ₩4.3t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩184,100.00
7D
-7.8%
1Y
8.2%
LigaChem Biosciences
Market Cap: ₩3.8t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩103,700.00
7D
-13.8%
1Y
-29.6%
OliX Pharmaceuticals
Market Cap: ₩2.9t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩136,600.00
7D
10.9%
1Y
225.2%
Voronoi
Market Cap: ₩2.6t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩145,600.00
7D
-12.4%
1Y
2.3%